Annual Current Liabilities
$168.80 K
-$739.60 K-81.42%
March 1, 2024
Summary
- As of February 25, 2025, VRAX annual total current liabilities is $168.80 thousand, with the most recent change of -$739.60 thousand (-81.42%) on March 1, 2024.
- During the last 3 years, VRAX annual current liabilities has fallen by -$702.60 thousand (-80.63%).
- VRAX annual current liabilities is now -86.45% below its all-time high of $1.25 million, reached on March 31, 2022.
Performance
VRAX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$694.00 K
+$525.20 K+311.14%
September 1, 2024
Summary
- As of February 25, 2025, VRAX quarterly total current liabilities is $694.00 thousand, with the most recent change of +$525.20 thousand (+311.14%) on September 1, 2024.
- Over the past year, VRAX quarterly current liabilities has stayed the same.
- VRAX quarterly current liabilities is now -44.27% below its all-time high of $1.25 million, reached on March 31, 2022.
Performance
VRAX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VRAX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.4% | 0.0% |
| 3 y3 years | -80.6% | 0.0% |
| 5 y5 years | -86.4% | 0.0% |
VRAX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.5% | at low | -44.3% | +311.1% |
| 5 y | 5-year | -86.5% | at low | -44.3% | +311.1% |
| alltime | all time | -86.5% | at low | -44.3% | +311.1% |
Virax Biolabs Group Limited Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $694.00 K(+311.1%) |
| Mar 2024 | $168.80 K(-81.4%) | $168.80 K(-78.6%) |
| Sep 2023 | - | $787.00 K(-13.4%) |
| Mar 2023 | $908.40 K | $908.40 K(-20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.14 M(-8.3%) |
| Mar 2022 | $1.25 M(+42.9%) | $1.25 M(+19.1%) |
| Sep 2021 | - | $1.05 M(+20.0%) |
| Mar 2021 | $871.40 K(-29.6%) | $871.40 K |
| Mar 2020 | $1.24 M | - |
FAQ
- What is Virax Biolabs Group Limited annual total current liabilities?
- What is the all time high annual current liabilities for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual current liabilities year-on-year change?
- What is Virax Biolabs Group Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited quarterly current liabilities year-on-year change?
What is Virax Biolabs Group Limited annual total current liabilities?
The current annual current liabilities of VRAX is $168.80 K
What is the all time high annual current liabilities for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual total current liabilities is $1.25 M
What is Virax Biolabs Group Limited annual current liabilities year-on-year change?
Over the past year, VRAX annual total current liabilities has changed by -$739.60 K (-81.42%)
What is Virax Biolabs Group Limited quarterly total current liabilities?
The current quarterly current liabilities of VRAX is $694.00 K
What is the all time high quarterly current liabilities for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high quarterly total current liabilities is $1.25 M
What is Virax Biolabs Group Limited quarterly current liabilities year-on-year change?
Over the past year, VRAX quarterly total current liabilities has changed by $0.00 (0.00%)